Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Category Archives: Stem Cell Treatment
Novel stem cell transplantation holds promise for HIV prevention
UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both the safety and efficacy of transplanting anti-HIV stem cells into mice that represent models of infected patients. The technique, which involves replacing the immune system with stem cells engineered with a triple combination of HIV-resistant genes, proved capable of replicating a normally functioning human immune system by protecting and expanding HIV-resistant immune cells Continue reading
Posted in Stem Cell Treatment
Tagged a-step-closer, aids, certain-strains, davis-health, davis-institute, fight-the-virus, gene-expression, hiv, joseph-anderson, journal, safety, stem-cells, team-, virus-
Comments Off
New muscular dystrophy treatment approach developed using human stem cells
ScienceDaily (May 4, 2012) Researchers from the University of Minnesota’s Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process that — for the first time — makes the production of human muscle cells from stem cells efficient and effective. The research, published May 4 in Cell Stem Cell, outlines the strategy for the development of a rapidly dividing population of skeletal myogenic progenitor cells (muscle-forming cells) derived from induced pluripotent (iPS) cells. Continue reading
Posted in Stem Cell Treatment
Tagged a-new-process, destruction, development, first, indeed-possible, lillehei-heart, medical, production, regulation, sets-the-stage, the-development, university
Comments Off
Cryo-Cell International Taps Leader in Stem Cell Therapy to Serve as Chief Scientific Officer
OLDSMAR, Fla., May 3, 2012 (GLOBE NEWSWIRE) — via PRWEB – Cryo-Cell International, Inc. announced the appointment of Linda Kelley, Ph.D., as chief scientific officer. Dr Continue reading
Posted in Stem Cell Treatment
Tagged a-national-cord, congress, cryo-, david-portnoy, director, institute, international, manufacturing, markets, medicine--, national, reports-on-form, science, success, university
Comments Off
BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
JUPITER, Fla., May 3, 2012 /PRNewswire/ –BioRestorative Therapies, Inc. (“BRT” or the “Company”) (BRTX.PK), a life sciences company focused on adult stem cell-based therapies, announced today that the latest version of its stem cell disc delivery device, which is to be used in the treatment of bulging and herniated discs, has shown improvements when compared to earlier versions. The first generation of the device had shown the potential to reduce disc bulges and avoid lower back surgery with a simple injection procedure. Continue reading
Posted in Stem Cell Treatment
Tagged easing-the-pain, press, press-release-, securities, statements-are, stem, study, treatment, weight-loss
Comments Off
Stem cell therapy for WCMS student has remarkable results
When Tyler was born, the umbilical cord was wrapped around his neck, causing a lack of oxygen to his brain that led to Tyler suffering a stroke during delivery. The stroke caused damage to the back of Tylers brain. Continue reading
Posted in Stem Cell Treatment
Tagged a-normal-life-, a-said-she, a-said-within, feet, flat-on-the, mexico, milestones, treatment, tyler-tyler, umbilical, with-umbilical
Comments Off
Pharmaceutical Company Merck Serono Signs an Agreement to Use Kadimastem's Platform for Drug Screening
NES ZIONA, Israel–(BUSINESS WIRE)– Kadimastem, an Israeli Biotechnology company that develops human pluripotent stem cell-related products, today announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. The agreement concerns the use of Kadimastem’s drug-screening platform to discover new oral drugs for the treatment of the neurological disease Multiple Sclerosis (MS). The system developed by Kadimastem allows using human functional tissues produced industrially from pluripotent stem cells as a means to search for potential new drugs, a direct approach that has advantages over the use of animals Continue reading
Posted in Stem Cell Treatment
Tagged a-leading-drug, agreement, capabilities, chief-scientist, embryonic, medical, merck, prof-revel, treatment, weizmann
Comments Off
VistaGen Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity
SOUTH SAN FRANCISCO, CA–(Marketwire -04/25/12)- VistaGen Therapeutics, Inc. Continue reading
Posted in Stem Cell Treatment
Tagged a-powerful-tool, a-serious-and, commercial, database, facebook, health, monitoring, ralph-snodgrass, rescue-variants, san, solidifies, toxicity-typing, vista
Comments Off
For Holliston teen, medical miracle or doctor fraud?
The treatment is experimental, not approved in the United States. Medical experts call it a scam. They call its overseas practitioners frauds Continue reading
Posted in Stem Cell Treatment
Tagged a-clinic-inside, a-has-cerebral, joanne-ghelli, mild-difference, neurology, perform-simple, the-procedure, treatment, united-states
Comments Off